Companies Dominating the Insect Cell Lines Market
- Thermo Fisher Scientific Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Sigma-Aldrich Corporation
- GE Healthcare Technologies Inc.
- Lonza Group
- Becton, Dickinson & Company
- HiMedia Laboratories LLC
- CellGenix GmbH
- Atlanta Biologicals Inc.
- PromoCell GmbH
- Merck
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of insect cell lines is evaluated at USD 1.23 billion.
The insect cell lines market size was over USD 1.12 billion in 2024 and is poised to exceed USD 4.61 billion by 2037, witnessing over 11.5% CAGR during the forecast period i.e., between 2025-2037. Increasing production of vaccines and the rising need for insect-derived products will drive the market growth.
North America industry is expected to account for largest revenue share of 35% by 2037, impelled by increasing spending on the production of vaccines in the region.
The major players in the market are Sigma-Aldrich Corporation, GE Healthcare Technologies Inc., Lonza Group, Becton, Dickinson & Company, HiMedia Laboratories LLC, Takara Bio Inc., CellGenix GmbH, Atlanta Biologicals Inc., PromoCell GmbH.
